[144] CONMED Corp SEC Filing

Rhea-AI Filing Summary

CONMED Corp (CNMD) Form 144 notice: The filer intends to sell 2,000 common shares through Fidelity Brokerage Services (Smithfield, RI) on or about 09/12/2025. The filing reports an aggregate market value of $107,049.37 and total shares outstanding of 30,954,963. The 2,000 shares were acquired from the issuer as compensation: 897 shares vested 06/01/2020, 335 vested 06/01/2023, 302 vested 05/31/2024, and 466 received via stock appreciation right on 09/06/2024. No sales by the reporting person in the past three months are reported. The filer signs the required representation that they are unaware of any undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR Routine insider disposition of vested equity: 2,000 shares for roughly $107k via a broker; not a large stake relative to outstanding shares.

The notice documents a planned sale executed through Fidelity Brokerage Services with clear provenance of the shares as compensation-based vesting and a SAR payout. The filing shows no other sales in the prior three months, which supports this being an isolated disposal rather than active trading. For market impact, 2,000 shares against 30,954,963 outstanding represents a de minimis transfer and is unlikely to move the stock price. The disclosure and broker details meet Rule 144 notice requirements.

Corporate Governance Expert

TL;DR Compliance-focused filing: issuer-originated equity vested and sold; the filing includes the required attestation about material nonpublic information.

The record clearly ties each block of shares to compensation events (restricted stock vesting and an SAR) with acquisition dates and payment nature, which enhances transparency. The filer attests they do not possess undisclosed material information, and no prior three-month sales are reported. From a governance standpoint, the form satisfies disclosure obligations under Rule 144 for an insider sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2000	107049.37	30954963	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2020	Restricted Stock Vesting	Issuer			897	06/01/2020	Compensation
Common	06/01/2023	Restricted Stock Vesting	Issuer			335	06/01/2023	Compensation
Common	05/31/2024	Restricted Stock Vesting	Issuer			302	05/31/2024	Compensation
Common	09/06/2024	SAR	Issuer			466	09/06/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CONMED (CNMD) report in this Form 144?

The filing notifies a proposed sale of 2,000 common shares through Fidelity Brokerage Services with an aggregate market value of $107,049.37 and an approximate sale date of 09/12/2025.

How were the 2,000 CONMED shares acquired?

All shares were acquired from the issuer as compensation: 897 vested 06/01/2020, 335 vested 06/01/2023, 302 vested 05/31/2024, and 466 from a SAR on 09/06/2024.

Does the filer report recent sales of CONMED stock in the past three months?

No. The Form 144 indicates "Nothing to Report" for securities sold during the past three months by the reporting person.

What attestation does the filer make on the Form 144?

The filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed and acknowledges the Rule 10b5-1 trading plan disclosure language if applicable.

Who will handle the sale of CONMED shares?

The sale is to be executed through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI.